4-Chloropyrrolo[2,3-D]Pyrimidine Bulk Price 2026 Global Manufacturer Analysis
- Market Outlook: 2026 pricing models reflect stabilized raw material costs for CAS 3680-69-1 intermediates.
- Quality Standards: Industrial purity exceeds 99% with full COA documentation for GMP compliance.
- Supply Security: Verified global manufacturer partners ensure consistent batch-to-batch reproducibility.
The pharmaceutical landscape for kinase inhibitors continues to evolve, driving sustained demand for critical heterocyclic building blocks. Among these, 4-Chloro-7H-pyrrolo[2,3-d]pyrimidine (CAS: 3680-69-1) remains a cornerstone scaffold for the synthesis of Janus kinase (JAK) inhibitors such as Tofacitinib. As we approach 2026, procurement managers and process chemists must navigate fluctuating bulk price structures while maintaining rigorous quality standards. This analysis provides a technical deep dive into market trends, volume discounting, and supply chain stability for this essential intermediate.
Analyzing 2026 Market Trends for 4-Chloropyrrolo[2,3-d]pyrimidine Bulk Price
The pricing dynamics for 6-Chloro-7-deazapurine derivatives are influenced heavily by the cost of precursor materials and energy consumption during the chlorination and cyclization stages. Market data indicates a shift towards long-term contracting rather than spot purchasing to mitigate volatility. For large-scale production, the bulk price is increasingly tied to the efficiency of the manufacturing process employed by the supplier.
Historical data suggests that research-grade quantities command significantly higher premiums per gram compared to metric ton-scale procurement. In 2026, buyers should expect pricing tiers to reflect logistical efficiencies and the purity grade required. High-performance liquid chromatography (HPLC) and gas chromatography (GC) standards now typically demand purity levels exceeding 98.0% for direct use in active pharmaceutical ingredient (API) synthesis. Suppliers capable of delivering consistent industrial purity without extensive downstream purification offer the most cost-effective solutions for commercial manufacturing.
Volume Discount Tiers Compared to Market Standards
Procurement strategies for heterocyclic intermediates often rely on volume-based incentives. While various market participants offer tiered pricing, the transparency of these tiers varies. A reliable global manufacturer will provide clear breakpoints for kilogram, multi-kilogram, and metric ton quantities. Below is a comparative overview of typical market pricing structures versus optimized industrial supply chains.
| Order Volume | Typical Market Grade | Estimated Price Range (USD) | Lead Time |
|---|---|---|---|
| 1g - 10g (Research) | 97% - 98% | $100 - $350 per gram | Immediate |
| 100g - 1kg (Pilot) | >98.0% (GC) | $500 - $800 per kg | 1-2 Weeks |
| 5kg - 25kg (Scale-up) | >99.0% (HPLC) | Negotiated Bulk Rate | 2-4 Weeks |
| 100kg+ (Commercial) | GMP Ready | Contract Manufacturing | 4-8 Weeks |
It is crucial to note that lower upfront costs often correlate with higher impurity profiles, which can increase overall process costs during API synthesis. NINGBO INNO PHARMCHEM CO.,LTD. distinguishes itself by offering competitive volume discounts that align with high-yield synthesis requirements, ensuring that the total cost of ownership remains low despite potential premium pricing on the raw intermediate.
Securing Supply Chain Stability with Verified Global Manufacturer Partners
Supply chain resilience is paramount for continuous API production. The synthesis of this pyrimidine derivative typically involves a multi-step synthesis route, beginning with α-alkylation reactions between diethyl malonate and allyl bromide. Subsequent cyclization with amidine forms the six-membered bislactam ring, followed by chlorination using phosphorus oxychloride. The final steps involve oxidation and nucleophilic substitution to achieve the final structure. A total yield of approximately 45.8% is standard for optimized five-step processes.
When sourcing high-purity 4-Chloropyrrolo[2,3-d]pyrimidine, buyers should verify that the supplier maintains robust quality control systems. Essential documentation includes a comprehensive Certificate of Analysis (COA), which details impurity profiles, residual solvents, and heavy metal content. Furthermore, safety data sheets (SDS) must align with global transport regulations, such as UN2811 for toxic solids.
Technical Specifications and Safety Profile
To ensure compatibility with downstream reactions, procurement teams must validate physical properties against their process parameters. The following table outlines the critical technical specifications required for commercial-grade material.
| Property | Specification | Test Method |
|---|---|---|
| CAS Number | 3680-69-1 | Verified |
| Molecular Formula | C6H4ClN3 | Calculated |
| Molecular Weight | 153.57 g/mol | MS |
| Melting Point | 188-194 °C | DSC / Capillary |
| Purity | >99.0% | HPLC / GC |
| Appearance | White to Tan Crystalline Powder | Visual |
| Storage Conditions | 2-8°C, Inert Atmosphere, Dark | Stability Study |
Safety protocols must be strictly adhered to during handling. The compound carries GHS06 danger symbols and hazard statements such as H301 (Toxic if swallowed). Proper personal protective equipment (PPE), including eyeshields, faceshields, and type P2 respirator cartridges, is mandatory during bulk handling. NINGBO INNO PHARMCHEM CO.,LTD. ensures all shipments comply with international hazardous material transport regulations, providing necessary documentation for customs and regulatory compliance.
Conclusion
As the demand for JAK inhibitors grows, the reliability of the intermediate supply chain becomes a critical competitive advantage. By prioritizing industrial purity and verified manufacturing process controls over lowest-initial-cost options, pharmaceutical companies can secure their production schedules against 2026 market fluctuations. Partnering with an established entity ensures access to consistent COA data and scalable volume capabilities.